Form 8-K - Current report:
SEC Accession No. 0001104659-23-025247
Filing Date
2023-02-24
Accepted
2023-02-24 13:46:32
Documents
12
Period of Report
2023-02-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237815d1_8k.htm   iXBRL 8-K 27299
  Complete submission text file 0001104659-23-025247.txt   199231

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20230224.xsd EX-101.SCH 3085
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20230224_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20230224_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT tm237815d1_8k_htm.xml XML 3477
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 23665593
SIC: 2834 Pharmaceutical Preparations